Overall rank by patents
#44,919
of 49,997 tracked assignees
USPTO PatentsView assignee record - 5 granted patents across 4 technology areas, recorded in grant years 2017–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).
The verdict
According to USPTO PatentsView, Atriva ranks #44,919 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 4 technology areas.
USPTO PatentsView assignee plate
Corpus R44919 · Foreign Corporation #44,919 · 5 grants
GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-FLAT · BOOK-FULL
Nearest grant-volume peer: Atom Nanoellectronics, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Airwair International · near
26 score
B &W Custom Truck Beds · near
26 score
World Wide Stationer… · near
26 score
Atriva Therapeutics · this assignee
26 score
3 Castles PTY · near
26 score
3D Lighting… · lowest
7 score
What this shows Atriva's Innovation Score is 25.7/100 (18th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Atriva Therapeutics GmbH is a focused PatentsView assignee: 4 CPC subclasses with 100% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). By volume, Atriva sits between Atom Nanoellectronics, Inc. and AudioByte LLC.
Atriva Therapeutics GmbH shows 1 grants in 2022–2024 against only 2 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Atom Nanoellectronics, Inc.
5 patents
Atom Tickets, LLC
5 patents
Atomi, Inc.
5 patents
Atoptech, Inc.
5 patents
Attralus, Inc
5 patents
Aucentra Therapeutics Pty Ltd
5 patents
Audio Fusion Systems, Inc.
5 patents
AudioByte LLC
5 patents
Atriva Therapeutics GmbH
5 patents
What this shows Atriva holds 5 patents at rank #44,976, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #44,976 in granted patent volume.
Other assignees with the most granted patents in Atriva's primary technology class.
Two PlainPatent-derived peer sets for Atriva, neither rank-band nor same-CPC leaders (those blocks stay above).
Nearest assignees by Innovation Score (26 here).
Atriva's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
26 18th percentile higher than 18% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2017 | 1 | 20.0% |
| 2019 | 1 | 20.0% |
| 2021 | 1 | 20.0% |
| 2024 | 1 | 20.0% |
| 2025partial year | 1 | 20.0% |
Top 4 of 4 technology areas
Overall rank by patents
#44,919
of 49,997 tracked assignees
25.7 out of 100
What to do with this data
Atriva Therapeutics GmbH's patent record in context - here's where to go next.
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.